COVID-19 vaccination and thyroiditis

24Citations
Citations of this article
25Readers
Mendeley users who have this article in their library.

Your institution provides access to this article.

Abstract

At the end of 2019, the world began to fight the coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus-2. Many vaccines have quickly been developed to control the epidemic, and with the widespread use of vaccines globally, several vaccine-related adverse events have been reported. This review mainly focused on COVID-19 vaccination-associated thyroiditis and summarized the current evidence regarding vaccine-induced subacute thyroiditis, silent thyroiditis, Graves’ disease, and Graves’ orbitopathy. The main clinical characteristics of each specific disease were outlined, and possible pathophysiological mechanisms were discussed. Finally, areas lacking evidence were specified, and a research agenda was proposed.

Cite

CITATION STYLE

APA

Şendur, S. N., Oğuz, S. H., & Ünlütürk, U. (2023, July 1). COVID-19 vaccination and thyroiditis. Best Practice and Research: Clinical Endocrinology and Metabolism. Bailliere Tindall Ltd. https://doi.org/10.1016/j.beem.2023.101759

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free